Potentsiometriskite titratsiite bea raboteniso koristenje na staklena i zasitena (KCl) kalomel elektroda. Op -re deluvaniot ketokonazol se rastvora vo rastvor na otsetna ki se -lina. Rastvor na HClO4 (0,1 mol*dm-3) vo otsetna kiselina besheko ri sten za titratsiite. Sekoj sm3 na HClO4 (0,1 mol*dm-3) e ekvi -valentno na 0,02657 g na ketokonazol. Napravena beshe HPLCanaliza na ketokonazol, vo prisustvo na ekonazol kako vnatreshenstandard, koristena e Ultrapac LiChrosorb RP 18 (5 mm) kolona, somobilnia faza koja se sostoi od 0,2% dietilamin vo metanol/0.5%rastvor na amonium atsetat (78:22); protok = 0,9 cm3/min i UVdetektsija na 224 nm.Rezultati i diskusijaOd dobienite rezultati e vidlivo deka razlikite pomegjudobienite vrednosti vo site metodi ne se statistichki znachajni. ZakluchokOpishanite metodi za kvantitativno opredeluvanje na ketokonazolvo farmatsevtski preparati se ednostavni i pretsizni. Tie mozhatda se vrshat direktno, bez otstranuvanje na drugite sostojki.Spektrofotometriskiot metod se preporachuva za kvantitativnoopredeluvanje vo rutinska analiza. Toj ne e samo zadovolitelnoreprodutsibilen, tuku i selektiven vo odnos na sostojkite. Iako,potentsiometriskiot metod ne mozhe da se smeta kako selektiven,toj e brz i dovolno reprodutsibilen za da se koristi kako alte r -na ti ven rutinski metod. HPLC metodot e osobeno korisen za op re -de luvanje na nechistotii i degradatsioni produkti vo studiite nasta bilnost.REFERENTsI1. European Pharmacopoeia (2008) 6th Ed., European Pharmacopoeia Commission2. The United States Pharmacopoeia 33th NF 29 (2010), Ed. Rockwille: United StatesPharmacopeial Convention3. Heyden, Y.V., A.N.M. Nguyet, M.R. Detaevernier, D.L. Massart & J.P. Vercammen (2002)J. Chromatogr. A 958 p. 191-2014. Arranz, P.; Arranz, A.; Moreda, J.M. ; Cid, A.;Arranz, J.F. (2003) J. Pharm.Biom. Anal., NewYork, 33, p. 589-5965. Inara Staub, Ana Maria Bergold (2004) Acta Farm. Bonaerense 23 (3) p.387-3906. Y Vander Heyde, A Nguyen Minh Nguyet, M R Detaevenier, D L Massart, J Plaizier-Vercammen(2002) Journal of Chromatography A 958 (1-2), p. 191-2017. El-Shabouri, S.R. ; Emara, K.M. ; Kashaba, P.Y. ;Mohamed, A.M (1998)Anal. Lett, New York, 31, p. 1367-1385VALIDATION AND QUANTIFICATION OFBACTERIAL ENDOTOXINS IN SOLUTIONSFOR HAEMODIALYSIS AMINAL-100B ANDAMINAL-100KElizabeta Popovska1, Hristina Babunovska1, Silvana Ilioska-Zlatanovic1, Maja Simjanovska1, Biserka Simonovska21ALKALOID A. D, Blvd. A. Makedonski 12, 1000 Skopje, R.Macedonia2Dijagnostika Farmahem, St.4-th July No.2/3, 1000 Skopje, R.MacedoniaINTRODUCTIONThe importance of endotoxin contamination in solutions for haemo -di alysis manufacturing becomes apparent when confronted with fouraspects of its existence: its ubiquity in nature, potent toxicity, stabil-ity or ability to retain after being subjected to extreme conditions andrelative likelihood of its occurrence in haemodialysis solutions.OBJECTIVEValidation of Bacterial endotoxins test for concentrated haemodialy-sis solutions AMINAL-100B and AMINAL-100K.23PHARMACEUTICAL ANALYSIS / QUALITY ASSURANCE / REGULATORY AFFAIRS poster presentationsFIFTH CONGRESS OF PHARMACY OF MACEDONIA WITH INTERNATIONAL PARTICIPATIONMacedonian Pharmaceutical Bulletin 57 (suppl), 2011METHODFor quantitative determination of bacterial endotoxins in concen-trated haemodialysis solutions, Kinetic turbidrimetric methodPYROGENT- 5000 has been used, along with Microplate reader Elx808.The results are calculated and stored with WIN QCL 3.1 software. TheKinetic turbidrimetric method is based on measuring the turbidity(optical density) of an LAL/sample mixture at regular intervaltroughout the test. The time required before the appearance ofturbidity (Reaction time) is inversely proportional to the amount ofendotoxin present. Solutions for haemodialysis are solutions of electrolytes with aconcentration close to the electrolytic composition of plasma.Because of the large volumes used, haemodialysis solutions are usuallyprepared by diluting a concentrated solution. pH problems are themost important biochemical cause of LAL-test inhibition. When deal-ing with acid or base solutions, correction of pH should be made inoptimum rang 6-8. AMINAL-100B has pH 8,3 and correction should bemade with LRW dilution. AMINAL-100K has acid pH 2,3 and correctionshould be made with 0,1 N NaOH . Concentrated haemodialysis solutions firstly should be diluted: AMI-NAL-100B (1,83: 36,83); AMINAL-100K(1:36,83) with water of suitablequality than pH correction should be made.RESULTSValidation has been made firstly with screening (Inhibition /Enhancement) test, upon received results the validation further wasdone on three series. For that purpose LONZA reagents have beenused; lysate sensitivity l = 0,01 EU/ml; MVD= ELC/l = 0,5 / 0,01 = 50.Dilutions used for preliminary, Inhibition / Enhancement test are: 1:2,1:4, 1:8, 1:16, 1:32 and 1:50.Concentrated haemodialysis solution AMINAL-100B is inhibitory upto 1/4 dilution inclusive. The inhibition was overcome at 1/8 dilutionwhich gave PPC recovery 81%. Upon received results the validationfurther was done on three series of AMINAL-100B with dilution 1:10.The endotoxin concentration reported is less than 0,100 EU/ml.Concentrated haemodialysis solution AMINAL-100K has low pH. Thisproperty makes it a powerful inhibitor of the LAL assay. pH adjust-ment has been made with 0,1N NaOH and the product was tested indilutions up to MVD. Since the inhibition was overcome, validationfurther was done on three series of AMINAL-10KB with dilution 1 : 2The endotoxin concentration reported is less than 0,020 EU/ml.CONCLUSIONSValidation of the Bacterial endotoxins test on Concentrated haemodial-ysis solutions AMINAL-100B and AMINAL-100K was successfully done.1. The inhibition was overcome at Concentrated haemodialysis solu-ti on AMINAL-100B. Routine testing should be done with dilution 1:10.2. The inhibition was overcome at Concentrated haemodialysis solu-tion AMINAL-100K. Routine testing should be done with dilution 1:2,after pH adjusting.REFERENCES1. Ph. Eur. 7 (2.6.14) & Haemodialysis solutions; 2. LAL Times Vol.8, No1 MARCH 2001; 3. PYROGENIC REACTIONS DURING HAEMODIALYSIS CAUSED BY EXTRAMURALENDOTOXIN; The Lancet, Volume 306, Issue 79384. EDTNA/ERCA Guidelines:Technical Section; Quality assurance for dialysis-qualitywater and dialysis fluidhttp://www.edtnaerca.org/pdf/education/WTguidelinesmicrob.pdf5. FDA - Guideline on Validation of the Limulus Amebocyte Lysate Test as an End-product Endotoxin Test for Human and Animal Parenteral Drugs, BiologicalProducts, and Medical Devices. U.S. Food and Drug Administration.6. ENDOTOXINS, Kevin L. WilliamsVALIDATsIJA I ODREDUVANjE NABAKTERISKI ENDOTOKSINI VORASTVORI ZA KhEMODIJALIZA AMINAL-100B I AMINAL-100KElizabeta Popovska1, Khristina Babunovska1 ,Silvana Ilioska-Zlatanovikj1 , Maja Simjanovska1, Biserka Simonovska21ALKALOID A. D, Bul. A. Makedonski 12, 1000 Skopje, Makedonija2Dijagnostika Farmakhem, Ul.4-ti Juli br.2/3,1000 Skopje, MakedonijaVOVEDVazhnosta na kontrolata na kontaminatsija so endotoksini priproizvodstvo na rastvori za khemodijaliza e ochigledna koga kje sesoochime so chetirite aspekti na nivnoto postoenje: nivnotoprisustvo vo prirodata, izrazenata toksichnost, stabilnosta naendotoksinite po izlozhuvanje na ekstremni uslovi i verojatnostaza nivno prisustvo vo rastvorite za khemodijaliza.TsELValidatsija na metodoloshka postapka za odreduvanje na bakteriskiendotoksini vo kontsentrirani r-ri za khemodijaliza AMINAL-100B i AMINAL-100K.METODABakteriskite endotoksini vo rastvorite za khemodijaliza seodreduvani so Kinetichko turbidimetriska metoda, reagensi PY-ROGENT- 5000, so Microplate reader Elx808cse koj koristi WIN QCL3.1 softver. Printsipot na metodata e merenje na turbiditetot(optichkata gustina) na smesata LAL/mostra vo odreden vremenskiintervali. Vremeto potrebno za pojava na turbiditet (reaktsionovreme) e obratno proportsionalno so kontsentratsijata nabakteriski endotoksini.Rastvorite za khemodijaliza se rastvori na elektroliti sokontsentratsija slichna na elektrolitniot sostav na plazmata.Bidejkji se koristat vo golem volumen se podgotvuvaat sorazreduvanje na kontsentriranite rastvori .>> pH vrednosta e kritichna tochka za izvedba na bakteriskiendotoksin test i zatoa e neopkhodna negova korektsija kajkiselite i baznite rastvori za khemodijaliza, vo opseg 6-8 .Kontsentriraniot r-r za khemodijaliza >> AMINAL-100B ima pH 8,3 i korektsijata se vrshi so dilutsija soLRW. Kontsentriraniot r-r za khemodijaliza AMINAL-100Kima kisel pH 2,3 i korektsijata na pH se vrshi so 0,1 N NaOH.>> Rastvorite prvo se doveduvaat do razreduvanje koe seupotrebuva za khemodijaliza: AMINAL-100B(1,83 : 36,83); AMI-NAL-100K (1 :36,83) , a potoa se vrshat korektsiite na pH.REZULTATIValidatsijata na metodite e napravena taka shto prvo e izrabotenskrining (Inkhibitsija /Zabrzuvanje), a potoa se vrshi validatsija natri serii. Upotrebuvani se reagensi od Lonza, lizat so sen zi ti v -nost l = 0,01 EU/ml; MVD = ELC/l = 0,5 / 0,01 = 50. Za testot In khi bi -tsija /Zabrzuvanje kaj dvata rastvora napraveni se sledniteraz reduvanja: 1:2, 1:4, 1:8, 1:16, 1:32 i 1:50.Kon tsentriraniot r-r za khemodijaliza AMINAL-100B pokazhuva in -khi bi tsija vkluchuvajkji go razreduvanjeto1:4. Inkhibitsijata se nadm i -24Makedonski farmatsevtski bilten 57 (dodatok), 2011FARMATsEVTSKI ANALIZI / OBEZBEDUVANjE KVALITET / REGULATIVA poster prezentatsiiPETTI KONGRES NA FARMATsIJATA SO MEGjUNARODNO UChESTVOn uva pri razreduvanje 1:8 koe dade PPC recovery 81%.Vrz osnova nado bienite rezultati od skriningot izvrshena e validatsija na triserii Kontsentriran r-r za khemodijaliza AMINAL-100B so dilutsija1 : 10 i pri toa se dobieni rezultati < 0,100EU/ml.Kontsentriraniot r-r za khemodijaliza AMINAL-100K ja inkhibirareaktsijata shto se dolzhi na niskiot pH , zatoa prvo mu se doteruvapH so 0,1 N NaOH , a potoa se vrshi dilutsija do MVD. Bidejkji nemainkhibitsija na reaktsijata po korektsija na pH, za validatsija na triserii se koristi dilutsija 1 :2. Kaj trite validirani serii dobienise rezultati < 0,020 EU/ml.ZAKLUChOTsIUspeshno e napravena validatsija na metodoloshkata po stapka za od -re duvanje na bakteriski endotoksini i doneseni se slednite za -klu cho tsi:>> Nadminata e inkhibitsijata na Kontsentriraniot r-r zakhemodijaliza AMINAL-100B. Pri rutinsko odreduvanje da seraboti so razreduvanje 1 : 10.>> Nadminata e inkhibitsijata na Kontsentriraniot r-r zakhemodijaliza AMINAL-100K. Pri rutinsko odreduvanje da seraboti so razreduvanje 1 : 2, po doteruvanjeto na pH.LITERATURA 1. Ph. Eur. 7 (2.6.14) & Haemodialysis solutions ; 2. LAL Times Vol.8, No1 MARCH 2001; 3. PYROGENIC REACTIONS DURING HAEMODIALYSIS CAUSED BY EXTRAMURALENDOTOXIN; The Lancet, Volume 306, Issue 79384. EDTNA/ERCA Guidelines:Technical Section; Quality assurance for dialysis-qualitywater and dialysis fluidhttp://www.edtnaerca.org/pdf/education/WTguidelinesmicrob.pdf5. FDA - Guideline on Validation of the Limulus Amebocyte Lysate Test as an End-product Endotoxin Test for Human and Animal Parenteral Drugs, BiologicalProducts, and Medical Devices. U.S. Food and Drug Administration.6. ENDOTOXINS, Kevin L. WilliamsDEVELOPMENT OF AN HPLC METHOD FORRELATED AND DEGRADATION PRODUCTSIN LOSARTAN FILM COATED TABLETS Marija Spasevska, Gordana Evgenievska, MenaIvanovska, Tatjana Bogovska, Hristina BabunovskaQuality Control Department, AD Alkaloid-Skopje, Pharmaceutical,Chemical and Cosmetic Company, A. Makedonski 12, Skopje, Mace-doniaLosartan is an angiotensin II receptor antagonist drug used mainly totreat high blood pressure (hypertension). It may also delay progressionof diabetic nephropathy and reduce renal disease progression. It isrecommended as first-line medicine for younger patients under 55 whocannot tolerate ACE inhibitor.